In their study, Chen et al. found that hyperoside—the main biologically active ingredient in Hypericum perforatum—dose-dependently reduces the levels of TNF-α and IL-6 in brain homogenate in rats, in a model of diabetes mellitus through antioxidants, anti-inflammatory and anti-apoptotic mechanisms. The gene discussed is IL6; the disease is diabetes mellitus.